Cited 111 times in
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.